B-lymphocyte activating factor levels are increased in patients with Wegener's granulomatosis and inversely correlated with ANCA titer.
about
Current and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitisPathogenesis of ANCA-associated vasculitisPathogenesis of ANCA-associated vasculitis.Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.Endothelium-neutrophil interactions in ANCA-associated diseasesPathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.Wegener's granulomatosis: a review of clinical features and an update in diagnosis and treatment.Biomarkers in ANCA-associated vasculitis.The multifaceted functions of neutrophils.B-cell-targeted therapy in adult glomerulonephritis.B cell-mediated pathogenesis of ANCA-mediated vasculitis.Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.Biologics for the treatment of autoimmune renal diseases.Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro.BAFF- and APRIL-targeted therapy in systemic autoimmune diseases.Decreases in the numbers of peripheral blood regulatory T cells, and increases in the levels of memory and activated B cells, in patients with active eosinophilic granulomatosis and polyangiitis.
P2860
Q27025692-7EC21C46-7EE1-493C-A1A1-9739BF21FBECQ27027790-5445F35F-B1AF-45CB-9B53-F120DD39C4A2Q28390438-F68B1498-637E-4273-96AE-2B1FB83DC3B2Q34296337-3737E9C5-CB1B-4E90-BCBC-A00806B9DB69Q34960458-D5FF7772-F6DD-4061-9FFD-022664EABEEAQ36200937-C91755FC-9926-4A25-9282-3BEC3AF44CDBQ37859110-4F8B90A7-4BA5-4C6B-AD97-F5BC43095D96Q38072743-95262608-BB62-49D0-81EC-B5363019D79DQ38129720-4E15612D-2DDF-49EE-B2FB-78C50F5D7215Q38139589-E0918226-B49B-4181-BB47-48C29980C53DQ38159787-D90FB950-CAF1-4ADE-9154-970B3B6C7904Q38207938-2AE7E1F4-9180-4FBD-96D4-19C40589EFDCQ38227267-693BA344-3E9C-4E20-A11B-BB48987461F8Q38763327-8D36B4C9-FBF0-4A1B-80CD-9EAECFB1D0A4Q40593657-428E6925-D8D3-4A6E-B43B-F356F3F88EA5Q47095865-1792589B-07E6-450B-BE64-803B544BA659Q50903151-82511241-9832-4317-B689-CC3423F3F550
P2860
B-lymphocyte activating factor levels are increased in patients with Wegener's granulomatosis and inversely correlated with ANCA titer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
B-lymphocyte activating factor ...... ly correlated with ANCA titer.
@en
B-lymphocyte activating factor ...... ly correlated with ANCA titer.
@nl
type
label
B-lymphocyte activating factor ...... ly correlated with ANCA titer.
@en
B-lymphocyte activating factor ...... ly correlated with ANCA titer.
@nl
prefLabel
B-lymphocyte activating factor ...... ly correlated with ANCA titer.
@en
B-lymphocyte activating factor ...... ly correlated with ANCA titer.
@nl
P1476
B-lymphocyte activating factor ...... ely correlated with ANCA titer
@en
P2093
Lucius Bader
Wenche Koldingsnes
P2860
P304
P356
10.1007/S10067-010-1526-Z
P577
2010-06-28T00:00:00Z